Kudel Ian, Alves Jefferson S, de Menezes Goncalves Thiago, Kull Kristjan, Nørtoft Emil
1Kantar Health, New York, USA.
Novo Nordisk Brazil, São Paulo, Brazil.
Diabetol Metab Syndr. 2018 Mar 16;10:20. doi: 10.1186/s13098-018-0322-9. eCollection 2018.
Obesity is associated with significant physical, psychosocial and economic burden globally. In Brazil, almost 50% of the population is either overweight or obese. The prevalence of morbid obesity increased by 255% between 1975 and 2003. The current study sought to quantify the relationship between weight status and health outcomes.
Data from three waves (2011, 2012, and 2015) of the Brazil National Health and Wellness Survey, an Internet-based survey administered to a demographically diverse sample of Brazilian adults, were used. Body mass index category was calculated based on self-reported height and weight and respondents were categorized into five groups (normal, overweight, obese class I, obese class II, obese class III; n = 34,254). Multivariable analyses, controlling for sociodemographic variables and health history, tested the association with body mass index group and outcomes including health status (Medical Outcomes Study Short Form 12-Item Health Survey version 2/Medical Outcomes Study Short Form 36-Item Health Survey version 2), work productivity (Work Productivity and Activity Impairment-General Health Questionnaire), and costs associated with work impairment (indirect costs), self-reported healthcare resource use and associated direct costs.
Overall, 53.6% of the surveyed Brazilian population reported being overweight or obese. In virtually all the analyses, increasing body mass index group was associated with significant and progressively worse outcomes. Most notable was the finding that hospitalization costs were over twice as high (R$3141.84 vs. R$1349.60) and indirect costs were nearly double (R$1656.80 vs. R$884.15) for obesity class III than for normal body mass index respondents.
Obesity rates in Brazil are considerable and, from a patient and societal perspective, increasingly burdensome, thereby highlighting the need for stakeholders to prioritize strategies for weight management interventions.
肥胖在全球范围内带来了巨大的身体、心理社会和经济负担。在巴西，近50%的人口超重或肥胖。1975年至2003年间，病态肥胖的患病率增长了255%。本研究旨在量化体重状况与健康结果之间的关系。
使用了巴西国家健康与幸福调查三轮（2011年、2012年和2015年）的数据，该调查是一项基于互联网的调查，对象为巴西成年人的人口统计学多样化样本。根据自我报告的身高和体重计算体重指数类别，受访者被分为五组（正常、超重、肥胖I类、肥胖II类、肥胖III类；n = 34254）。多变量分析在控制社会人口统计学变量和健康史的情况下，测试了与体重指数组以及包括健康状况（医学结果研究简表12项健康调查第2版/医学结果研究简表36项健康调查第2版）、工作生产力（工作生产力和活动障碍-一般健康问卷）以及与工作障碍相关的成本（间接成本）、自我报告的医疗资源使用和相关直接成本等结果之间的关联。
总体而言，53.6%的受访巴西人口报告超重或肥胖。在几乎所有分析中，体重指数组增加与显著且逐渐恶化的结果相关。最值得注意的发现是，肥胖III类受访者的住院费用是正常体重指数受访者的两倍多（分别为3141.84雷亚尔和1349.60雷亚尔），间接成本几乎是两倍（分别为1656.80雷亚尔和884.15雷亚尔）。
巴西的肥胖率相当高，从患者和社会角度来看，负担越来越重，从而凸显了利益相关者将体重管理干预策略列为优先事项的必要性。
Zotero 插件